OOIR: Observatory of International Research

Papers

(The H4-Index of Best Practice & Research Clinical Endocrinology & Metabolism is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	91
Editorial Board	90
Editorial Board	89
The pathophysiology of hypophosphatemia	86
Publisher's Note	61
Editorial Board	59
Hormone therapy regimens for managing the menopause and premature ovarian insufficiency	50
Burosumab: Current status and future prospects	45
Premature ovarian insufficiency, early menopause, and induced menopause	44
SDH-related head and neck paragangliomas: Unraveling PET radiomics beyond 18F-FDG	42
Editorial Board	42
Genetics of reproductive endocrinology	41
Genotype-phenotype correlations in Graves’ disease	40
Developments in interventional management of hepatic metastases from neuroendocrine tumours	40
COVID-19 vaccination and thyroiditis	37
Editorial Board	37
Editorial Board	35
Surgical outcomes in patients with acromegaly: Microscopic vs. endoscopic transsphenoidal surgery	35
Editorial Board	33
Editorial Board	33
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	33
Second line treatment of acromegaly: Pasireotide or Pegvisomant?	31
The novel concept of “Onco-Immuno-Endocrinology” led to the discovery of new clinical entity “paraneoplastic autoimmune hypophysitis”	30
Tyrosine Kinase Inhibitors and Immunotherapy Updates in Neuroendocrine Neoplasms	30
Editorial Board	29

Menopausal hormone therapy for the management of osteoporosis	27
Next-generation therapeutic bacteria for treatment of obesity, diabetes, and other endocrine diseases	27